1. Home
  2. FENG vs RANI Comparison

FENG vs RANI Comparison

Compare FENG & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENG
  • RANI
  • Stock Information
  • Founded
  • FENG 1998
  • RANI 2012
  • Country
  • FENG China
  • RANI United States
  • Employees
  • FENG N/A
  • RANI N/A
  • Industry
  • FENG Broadcasting
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • FENG Industrials
  • RANI Health Care
  • Exchange
  • FENG Nasdaq
  • RANI Nasdaq
  • Market Cap
  • FENG 26.8M
  • RANI 23.2M
  • IPO Year
  • FENG 2011
  • RANI 2021
  • Fundamental
  • Price
  • FENG $2.82
  • RANI $0.49
  • Analyst Decision
  • FENG
  • RANI Strong Buy
  • Analyst Count
  • FENG 0
  • RANI 4
  • Target Price
  • FENG N/A
  • RANI $7.75
  • AVG Volume (30 Days)
  • FENG 5.1K
  • RANI 682.2K
  • Earning Date
  • FENG 08-12-2025
  • RANI 08-07-2025
  • Dividend Yield
  • FENG N/A
  • RANI N/A
  • EPS Growth
  • FENG N/A
  • RANI N/A
  • EPS
  • FENG N/A
  • RANI N/A
  • Revenue
  • FENG $101,168,374.00
  • RANI $1,200,000.00
  • Revenue This Year
  • FENG N/A
  • RANI N/A
  • Revenue Next Year
  • FENG N/A
  • RANI N/A
  • P/E Ratio
  • FENG N/A
  • RANI N/A
  • Revenue Growth
  • FENG 5.53
  • RANI N/A
  • 52 Week Low
  • FENG $1.28
  • RANI $0.39
  • 52 Week High
  • FENG $3.49
  • RANI $3.75
  • Technical
  • Relative Strength Index (RSI)
  • FENG 75.09
  • RANI 41.45
  • Support Level
  • FENG $2.37
  • RANI $0.45
  • Resistance Level
  • FENG $2.35
  • RANI $0.58
  • Average True Range (ATR)
  • FENG 0.15
  • RANI 0.05
  • MACD
  • FENG 0.05
  • RANI -0.01
  • Stochastic Oscillator
  • FENG 73.12
  • RANI 18.76

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: